Open label, prospective study for the Biofourmis Everion armband telemonitoring solution for patients during COVID-19 home isolation within South Western Sydney

Open label, prospective study for the Biofourmis Everion armband telemonitoring solution for patients during COVID-19 home isolation within South West Sydney to assess the feasibility and suitability of the Everion armband device in the telemonitoring of COVID-19 high risk patients under home isolation period

Status

Not yet recruiting

Phases

Unknown

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12620000635965

Acronym

BEAT Biofourmis Everion Armband Telemonitoring

Enrollment

Registered

2020-05-29

Start date

2020-06-05

Completion date

2020-08-31

Last updated

2020-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

People confirmed positive with COVID-19 are often managed at home in home isolation and receive regular contact from the hospital team to manage their care. This study is to assess the feasibility and suitability of the Everion armband device on top of this management for COVID-19 high risk patients under home isolation period.

Interventions

Patients recently diagnosed with COVID-19 who are currently under home isolation protocol or about to undergo home isolation will be considered as potential participants. Consented participants will be provided with the Everion armband and educated in the utilisation and care of the technology. The education will take approximately 15-20 minutes and be provided by the Triple-I Nurse either in person at the participants home or over video/ telephone call. Participants will be monitored for changes in temperature, heart rate, respiratory rate, oxygen levels and symptoms of COVID-19 for the length of their isolation period until clinical clearance is granted. Biometric readings and alerts will be monitored by the clinical staff from the Triple I (Hub) who will escalate to the relevant doctor for a consultation and a decision will be made on the participants clinical care as per SWSLHD Procedure for "Follow-up of Positive COVID-19 patients in home isolation".

Study design

Allocation

Non-randomised trial

Intervention model

Single group

Primary purpose

Prevention

Masking

Open (masking not used)

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

Aged 18 years or above COVID-19 positive and undergoing/to undergo home isolation protocol Able to follow and complete instructions and questionnaires Able to provide own informed consent

Exclusion criteria

High risk patient in need of hospitalization/in-patient No consent signed

Outcome results